143 Thousand. That is the number of people in the US expected to lose their battle with Lung Cancer this year. We need more treatment options; and at Novartis we are reimagining medicine to provide innovative therapies to address this challenge. We are looking for curious,
energized, passionate people to join us to be help bring new products to market. Maybe that's you.
As the Sr. Director for Lung Cancer, you will be responsible for driving a potential new therapy for non-small cell lung cancer, leading the development, implementation and execution of portfolio/brand strategy. Alongside these business responsibilities, you will also lead and develop a team of direct reports, and cross-functional partners.
Your responsibilities will include but are not limited to:
You will be accountable to develop and evolve brands' vision, strategy, positioning, value proposition and strategic imperatives across a brand focusing on MET+- non small cell lung cancer (NSCLC).
You will be developing a comprehensive set of sales forecast scenarios and sensitivity analyses across the brands.
You will drive new insights through integration of information from all customer groups, making trade-off decisions and recommends priority strategy and approach.
Leading cross-functional teams to align and execute lung strategy and tactics.
Cultivate and leverage key opinion leaders to shape and deliver on brand strategy, generating stakeholder advocacy plans to prepare for new products/indications.
You will partner with Market Access to develop and maintain pricing strategies and reimbursement models to optimize market success.
Collaborate closely with CDx team to maximize testing environment and to support strong launch trajectory.